APA (7th ed.) Citation

H, S., M, S., S, K., S, T., A, O., T, I., . . . H, N. (2026). Assessment of Multiple Prognostic Scores in Patients With Metastatic Renal Cell Carcinoma Receiving First-Line, Immune-Based Combinations. Cancer reports (Hoboken, N.J.), 9(6), e70604. https://doi.org/10.1002/cnr2.70604

Chicago Style (17th ed.) Citation

H, Sakurai, et al. "Assessment of Multiple Prognostic Scores in Patients With Metastatic Renal Cell Carcinoma Receiving First-Line, Immune-Based Combinations." Cancer Reports (Hoboken, N.J.) 9, no. 6 (2026): e70604. https://doi.org/10.1002/cnr2.70604.

MLA (9th ed.) Citation

H, Sakurai, et al. "Assessment of Multiple Prognostic Scores in Patients With Metastatic Renal Cell Carcinoma Receiving First-Line, Immune-Based Combinations." Cancer Reports (Hoboken, N.J.), vol. 9, no. 6, 2026, p. e70604, https://doi.org/10.1002/cnr2.70604.